NVO

NVO

USD

Novo Nordisk A/S Common Stock

$45.700-0.520 (-1.125%)

실시간 가격

Healthcare
Drug Manufacturers - General
덴마크

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$46.220

고가

$46.360

저가

$45.570

거래량

37.86M

기업 기본 정보

시가총액

210.1B

산업

Drug Manufacturers - General

국가

Denmark

거래 통계

평균 거래량

15.16M

거래소

NYQ

통화

USD

52주 범위

저가 $45.05현재가 $45.700고가 $112.52

관련 뉴스

CNBC

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.

더 보기
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
CNBC

Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech

The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.

더 보기
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
CNBC

November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk

Here are five key things investors need to know to start the trading day.

더 보기
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
CNBC

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.

더 보기
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound